ISSN: 1838-7640Theranostics
Global reach, higher impact
Theranostics 2020; 10(16):7401-7402. doi:10.7150/thno.47923 This issue Cite
Erratum
The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum
Jingfeng Zhou, Bei Jin, Yanli Jin, Yizhi Liu, Jingxuan Pan 
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 54 S. Xianlie Road, Guangzhou, 510060, China
Citation:
Zhou J, Jin B, Jin Y, Liu Y, Pan J. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics 2020; 10(16):7401-7402. doi:10.7150/thno.47923. https://www.thno.org/v10p7401.htm
Other stylesCorrected-article in Theranostics, Volume 7, 1447
In our article [1], there were one misplaced image in Fig. 2C and Fig. 6B, respectively. The corrected version of Figure 2C and Figure 6B are provided here.
Figure 2C
UM cells were exposed to niclosamide for 48 h, Western blot analysis of cytochrome c in the cytosolic extracts.
Figure 6B
Mel270 and Omm2.3 cells were treated with niclosamide (1 μmol/L) for 48 h, and the percentage of Aldefluor+ cells was determined by flow cytometry. Representative flow cytometry data and bar graph with SD from 3 independent experiments are shown. **, p< 0.01; ***, p< 0.001, Student's t test.
In addition, the description of the whole section regarding all the supported grants originally stated in the acknowledgements in the initially published version of this article [1] is replaced with: The study was supported by grant (Grant 2015A030312014 to J. Pan) from Natural Science Foundation of Guangdong Province.
The corrections made in this erratum do not affect the original conclusions. The authors apologize for any inconvenience or misunderstanding that these errors may have caused.
References
1. Zhou J, Jin B, Jin Y, Liu Y, Pan J. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo. Theranostics. 2017;7(6):1447-1462 doi:10.7150/thno.17451
Author contact
Corresponding author: Jingxuan Pan, M.D., Ph.D., State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 54 S. Xianlie Road, Guangzhou 510060, People's Republic of China, Phone: +86-20-37628262, E-mail: panjx2sysu.edu.cn
Published 2020-6-10
Citation styles
APA
Zhou, J., Jin, B., Jin, Y., Liu, Y., Pan, J. (2020). The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics, 10(16), 7401-7402. https://doi.org/10.7150/thno.47923.
ACS
Zhou, J.; Jin, B.; Jin, Y.; Liu, Y.; Pan, J. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics 2020, 10 (16), 7401-7402. DOI: 10.7150/thno.47923.
NLM
Zhou J, Jin B, Jin Y, Liu Y, Pan J. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics 2020; 10(16):7401-7402. doi:10.7150/thno.47923. https://www.thno.org/v10p7401.htm
CSE
Zhou J, Jin B, Jin Y, Liu Y, Pan J. 2020. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics. 10(16):7401-7402.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.